News
MGTX
4.860
-1.42%
-0.070
Weekly Report: what happened at MGTX last week (0415-0419)?
Weekly Report · 2d ago
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
MeiraGTx Holdings plc is a vertically integrated, clinical stage gene therapy company. The Company gave an oral presentation at the American Academy of Oral Medicine Annual Conference. The conference will be held from April 16-20, 2024 in Orlando, Florida.
Barchart · 6d ago
Weekly Report: what happened at MGTX last week (0408-0412)?
Weekly Report · 04/15 09:18
MeiraGTx Holdings Breaks Above 200-Day Moving Average - Bullish for MGTX
NASDAQ · 04/09 16:21
Weekly Report: what happened at MGTX last week (0401-0405)?
Weekly Report · 04/08 09:19
Private equity firms among MeiraGTx Holdings plc's (NASDAQ:MGTX) largest stockholders and were hit after last week's 10% price drop
Top 6 shareholders of MeiraGTx Holdings plc own 55% of the company. The company is owned by private equity firms with 28% of its shares. The general public holds a 21% stake in the company, with 19% held by institutions. Meira GTx Holdings has an insider ownership of some of the shares in the firm. The group of shareholders may have more power to influence the company's decisions.
Simply Wall St · 04/03 10:02
Weekly Report: what happened at MGTX last week (0325-0329)?
Weekly Report · 04/01 09:18
Weekly Report: what happened at MGTX last week (0318-0322)?
Weekly Report · 03/25 09:19
Weekly Report: what happened at MGTX last week (0311-0315)?
Weekly Report · 03/18 09:18
MeiraGTx Holdings Price Target Maintained With a $11.00/Share by RBC Capital
Dow Jones · 03/15 16:33
RBC Capital Reiterates Outperform on MeiraGTx Hldgs, Maintains $11 Price Target
Benzinga · 03/15 16:23
Buy Rating Affirmed: Meiragtx Holdings’ Promising Pipeline and Strategic Partnerships Set Stage for Growth
TipRanks · 03/15 11:46
RBC Capital Sticks to Their Buy Rating for Meiragtx Holdings (MGTX)
TipRanks · 03/15 10:47
MGTX Stock Earnings: MeiraGTx Hldgs Beats EPS, Misses Revenue for Q4 2023
MeiraGTx Hldgs reported earnings per share of 42 cents for the fourth quarter of 2023. The company reported revenue of $2.04 million. This was 68.90% worse than the analyst estimate of $6.56 million for the quarter.
Investorplace · 03/15 01:54
Recap: MeiraGTx Hldgs Q4 Earnings
MeiraGTx Hldgs reported its Q4 earnings of $0.42 on March 14. The company's revenue was up $7.33 million from the same period last year. MeiraGT xhldgs beat estimates by 482.0%. The company is expected to announce its earnings Thursday morning.
Benzinga · 03/14 21:50
MeiraGTx GAAP EPS of -$1.49, revenue of $14M
Seeking Alpha · 03/14 15:35
MeiraGTx Holdings PLC reports results for the quarter ended in December - Earnings Summary
MeiraGTx Holdings PLC reports results for the quarter ended in December. The company reported a quarterly adjusted loss of 42 cents per share. Revenue was $2.04 million; analysts expected $6.56 million. Wall Street's median 12-month price target for the company is $20.00.
Reuters · 03/14 14:20
*MeiraGTx Holdings 2023 Rev $14M >MGTX
Dow Jones · 03/14 12:32
Press Release: MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates. Company aligned with FDA on requirements for ongoing Phase 2 AQUAx2 clinical trial for radiation-induced xerostomia. Company to present positive data on AAV-AIPL1 treatment of 8 LCA4 patients in Parkinson's disease in second quarter 2024. Entered into an asset purchase agreement with Janssen Pharmaceuticals for the treatment of X-linked retinitis pigmentosa.
Dow Jones · 03/14 12:30
FACTBOX-Who are OpenAI's new board members?
Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three directors. Altman had returned as CEO of the company just four days after his sudden ouster in November. The board will expand with the addition of Sue Desmond-Hellmann, Nicole Seligman and Instacart CEO Fidji Simo.
Reuters · 03/11 14:42
More
Webull provides a variety of real-time MGTX stock news. You can receive the latest news about Meiragtx Holdings Plc through multiple platforms. This information may help you make smarter investment decisions.
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.